nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbimazole—TPO—Differentiation Pathway—CNTF—glaucoma	0.0323	0.347	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—NTF4—glaucoma	0.017	0.182	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—IL1A—glaucoma	0.00585	0.0628	CbGpPWpGaD
Carbimazole—Myalgia—Metipranolol—glaucoma	0.00538	0.00594	CcSEcCtD
Carbimazole—Discomfort—Metipranolol—glaucoma	0.00532	0.00587	CcSEcCtD
Carbimazole—Leukopenia—Diclofenamide—glaucoma	0.00515	0.00568	CcSEcCtD
Carbimazole—Liver function test abnormal—Brinzolamide—glaucoma	0.00507	0.00559	CcSEcCtD
Carbimazole—Ill-defined disorder—Methazolamide—glaucoma	0.00492	0.00543	CcSEcCtD
Carbimazole—Liver function test abnormal—Pilocarpine—glaucoma	0.00487	0.00537	CcSEcCtD
Carbimazole—Malaise—Methazolamide—glaucoma	0.00478	0.00527	CcSEcCtD
Carbimazole—Leukopenia—Methazolamide—glaucoma	0.00475	0.00523	CcSEcCtD
Carbimazole—Haemorrhage—Apraclonidine—glaucoma	0.00471	0.0052	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Metipranolol—glaucoma	0.0047	0.00518	CcSEcCtD
Carbimazole—Thrombocytopenia—Diclofenamide—glaucoma	0.0046	0.00507	CcSEcCtD
Carbimazole—Mouth ulceration—Betaxolol—glaucoma	0.00457	0.00504	CcSEcCtD
Carbimazole—Infection—Carbachol—glaucoma	0.00456	0.00503	CcSEcCtD
Carbimazole—Oropharyngeal pain—Timolol—glaucoma	0.00454	0.00501	CcSEcCtD
Carbimazole—Discomfort—Methazolamide—glaucoma	0.00446	0.00492	CcSEcCtD
Carbimazole—Agranulocytosis—Acetazolamide—glaucoma	0.00438	0.00483	CcSEcCtD
Carbimazole—Arthralgia—Latanoprost—glaucoma	0.00437	0.00482	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Latanoprost—glaucoma	0.00434	0.00479	CcSEcCtD
Carbimazole—Discomfort—Latanoprost—glaucoma	0.00432	0.00476	CcSEcCtD
Carbimazole—Angiopathy—Apraclonidine—glaucoma	0.00428	0.00472	CcSEcCtD
Carbimazole—Angiopathy—Bimatoprost—glaucoma	0.00415	0.00457	CcSEcCtD
Carbimazole—Nervous system disorder—Latanoprost—glaucoma	0.00411	0.00453	CcSEcCtD
Carbimazole—Skin disorder—Latanoprost—glaucoma	0.00407	0.00449	CcSEcCtD
Carbimazole—Agranulocytosis—Dorzolamide—glaucoma	0.00402	0.00443	CcSEcCtD
Carbimazole—Stomatitis—Pilocarpine—glaucoma	0.00397	0.00437	CcSEcCtD
Carbimazole—Liver function test abnormal—Clonidine—glaucoma	0.00389	0.00429	CcSEcCtD
Carbimazole—Feeling abnormal—Diclofenamide—glaucoma	0.00387	0.00427	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Latanoprost—glaucoma	0.00382	0.00421	CcSEcCtD
Carbimazole—Ill-defined disorder—Apraclonidine—glaucoma	0.00381	0.0042	CcSEcCtD
Carbimazole—Hypersensitivity—Metipranolol—glaucoma	0.0038	0.00419	CcSEcCtD
Carbimazole—Feeling abnormal—Levobunolol—glaucoma	0.00372	0.00411	CcSEcCtD
Carbimazole—Body temperature increased—Diclofenamide—glaucoma	0.00372	0.0041	CcSEcCtD
Carbimazole—Malaise—Apraclonidine—glaucoma	0.0037	0.00408	CcSEcCtD
Carbimazole—Angiopathy—Brimonidine—glaucoma	0.00367	0.00405	CcSEcCtD
Carbimazole—Hepatitis—Pilocarpine—glaucoma	0.00365	0.00403	CcSEcCtD
Carbimazole—Body temperature increased—Carbachol—glaucoma	0.00363	0.004	CcSEcCtD
Carbimazole—Urticaria—Levobunolol—glaucoma	0.00359	0.00396	CcSEcCtD
Carbimazole—Feeling abnormal—Methazolamide—glaucoma	0.00357	0.00393	CcSEcCtD
Carbimazole—Hypersensitivity—Carteolol—glaucoma	0.00352	0.00388	CcSEcCtD
Carbimazole—Myalgia—Apraclonidine—glaucoma	0.00349	0.00385	CcSEcCtD
Carbimazole—Angiopathy—Travoprost—glaucoma	0.00349	0.00385	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Apraclonidine—glaucoma	0.00347	0.00383	CcSEcCtD
Carbimazole—CYP19A1—Endogenous sterols—CYP1B1—glaucoma	0.00345	0.0371	CbGpPWpGaD
Carbimazole—Discomfort—Apraclonidine—glaucoma	0.00345	0.00381	CcSEcCtD
Carbimazole—Angiopathy—Brinzolamide—glaucoma	0.00345	0.0038	CcSEcCtD
Carbimazole—Urticaria—Methazolamide—glaucoma	0.00344	0.00379	CcSEcCtD
Carbimazole—Body temperature increased—Methazolamide—glaucoma	0.00342	0.00377	CcSEcCtD
Carbimazole—Alopecia—Dorzolamide—glaucoma	0.00342	0.00377	CcSEcCtD
Carbimazole—Ill-defined disorder—Acetazolamide—glaucoma	0.00341	0.00376	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.00336	0.00371	CcSEcCtD
Carbimazole—Alopecia—Brinzolamide—glaucoma	0.00336	0.0037	CcSEcCtD
Carbimazole—Hypersensitivity—Levobunolol—glaucoma	0.00333	0.00367	CcSEcCtD
Carbimazole—Infection—Apraclonidine—glaucoma	0.00333	0.00367	CcSEcCtD
Carbimazole—Pruritus—Diclofenamide—glaucoma	0.00333	0.00367	CcSEcCtD
Carbimazole—Malaise—Acetazolamide—glaucoma	0.00331	0.00365	CcSEcCtD
Carbimazole—Leukopenia—Acetazolamide—glaucoma	0.00329	0.00362	CcSEcCtD
Carbimazole—Nervous system disorder—Apraclonidine—glaucoma	0.00328	0.00362	CcSEcCtD
Carbimazole—Rash—Metipranolol—glaucoma	0.00325	0.00359	CcSEcCtD
Carbimazole—Skin disorder—Apraclonidine—glaucoma	0.00325	0.00359	CcSEcCtD
Carbimazole—Dermatitis—Metipranolol—glaucoma	0.00325	0.00358	CcSEcCtD
Carbimazole—Headache—Metipranolol—glaucoma	0.00323	0.00356	CcSEcCtD
Carbimazole—Alopecia—Pilocarpine—glaucoma	0.00323	0.00356	CcSEcCtD
Carbimazole—Infection—Bimatoprost—glaucoma	0.00323	0.00356	CcSEcCtD
Carbimazole—Pruritus—Levobunolol—glaucoma	0.0032	0.00352	CcSEcCtD
Carbimazole—Nervous system disorder—Bimatoprost—glaucoma	0.00318	0.00351	CcSEcCtD
Carbimazole—Skin disorder—Bimatoprost—glaucoma	0.00315	0.00348	CcSEcCtD
Carbimazole—Ill-defined disorder—Travoprost—glaucoma	0.00311	0.00343	CcSEcCtD
Carbimazole—Discomfort—Acetazolamide—glaucoma	0.00309	0.0034	CcSEcCtD
Carbimazole—Angioedema—Dorzolamide—glaucoma	0.00307	0.00339	CcSEcCtD
Carbimazole—Ill-defined disorder—Brinzolamide—glaucoma	0.00307	0.00338	CcSEcCtD
Carbimazole—Nausea—Metipranolol—glaucoma	0.00307	0.00338	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Apraclonidine—glaucoma	0.00305	0.00336	CcSEcCtD
Carbimazole—Malaise—Travoprost—glaucoma	0.00302	0.00333	CcSEcCtD
Carbimazole—Myalgia—Brimonidine—glaucoma	0.003	0.00331	CcSEcCtD
Carbimazole—Arthralgia—Brimonidine—glaucoma	0.003	0.00331	CcSEcCtD
Carbimazole—Headache—Carteolol—glaucoma	0.00299	0.0033	CcSEcCtD
Carbimazole—Malaise—Brinzolamide—glaucoma	0.00298	0.00329	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.00298	0.00328	CcSEcCtD
Carbimazole—Pruritus—Latanoprost—glaucoma	0.00296	0.00327	CcSEcCtD
Carbimazole—Rash—Diclofenamide—glaucoma	0.00296	0.00327	CcSEcCtD
Carbimazole—Discomfort—Brimonidine—glaucoma	0.00296	0.00327	CcSEcCtD
Carbimazole—Headache—Diclofenamide—glaucoma	0.00294	0.00325	CcSEcCtD
Carbimazole—Thrombocytopenia—Acetazolamide—glaucoma	0.00293	0.00323	CcSEcCtD
Carbimazole—Hepatitis—Clonidine—glaucoma	0.00292	0.00322	CcSEcCtD
Carbimazole—Rash—Carbachol—glaucoma	0.00289	0.00319	CcSEcCtD
Carbimazole—Dermatitis—Carbachol—glaucoma	0.00289	0.00319	CcSEcCtD
Carbimazole—Headache—Carbachol—glaucoma	0.00287	0.00317	CcSEcCtD
Carbimazole—Arthralgia—Dorzolamide—glaucoma	0.00286	0.00316	CcSEcCtD
Carbimazole—Infection—Brimonidine—glaucoma	0.00286	0.00315	CcSEcCtD
Carbimazole—Arthralgia—Travoprost—glaucoma	0.00285	0.00314	CcSEcCtD
Carbimazole—Myalgia—Travoprost—glaucoma	0.00285	0.00314	CcSEcCtD
Carbimazole—Leukopenia—Pilocarpine—glaucoma	0.00285	0.00314	CcSEcCtD
Carbimazole—Nausea—Carteolol—glaucoma	0.00284	0.00313	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.00283	0.00312	CcSEcCtD
Carbimazole—Headache—Levobunolol—glaucoma	0.00283	0.00312	CcSEcCtD
Carbimazole—Discomfort—Dorzolamide—glaucoma	0.00283	0.00312	CcSEcCtD
Carbimazole—Nervous system disorder—Brimonidine—glaucoma	0.00282	0.00311	CcSEcCtD
Carbimazole—Discomfort—Travoprost—glaucoma	0.00282	0.00311	CcSEcCtD
Carbimazole—Arthralgia—Brinzolamide—glaucoma	0.00282	0.00311	CcSEcCtD
Carbimazole—Myalgia—Brinzolamide—glaucoma	0.00282	0.00311	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.0028	0.00308	CcSEcCtD
Carbimazole—Skin disorder—Brimonidine—glaucoma	0.00279	0.00308	CcSEcCtD
Carbimazole—Nausea—Diclofenamide—glaucoma	0.00279	0.00308	CcSEcCtD
Carbimazole—Discomfort—Brinzolamide—glaucoma	0.00278	0.00307	CcSEcCtD
Carbimazole—Liver function test abnormal—Timolol—glaucoma	0.00277	0.00305	CcSEcCtD
Carbimazole—Feeling abnormal—Apraclonidine—glaucoma	0.00276	0.00304	CcSEcCtD
Carbimazole—Stomatitis—Betaxolol—glaucoma	0.00276	0.00304	CcSEcCtD
Carbimazole—Rash—Methazolamide—glaucoma	0.00273	0.00301	CcSEcCtD
Carbimazole—Dermatitis—Methazolamide—glaucoma	0.00273	0.00301	CcSEcCtD
Carbimazole—Nausea—Carbachol—glaucoma	0.00272	0.003	CcSEcCtD
Carbimazole—Infection—Travoprost—glaucoma	0.00272	0.003	CcSEcCtD
Carbimazole—Headache—Methazolamide—glaucoma	0.00271	0.00299	CcSEcCtD
Carbimazole—Myalgia—Pilocarpine—glaucoma	0.00271	0.00298	CcSEcCtD
Carbimazole—Arthralgia—Pilocarpine—glaucoma	0.00271	0.00298	CcSEcCtD
Carbimazole—Nausea—Levobunolol—glaucoma	0.00268	0.00296	CcSEcCtD
Carbimazole—Infection—Brinzolamide—glaucoma	0.00268	0.00296	CcSEcCtD
Carbimazole—Nervous system disorder—Travoprost—glaucoma	0.00268	0.00296	CcSEcCtD
Carbimazole—Discomfort—Pilocarpine—glaucoma	0.00267	0.00295	CcSEcCtD
Carbimazole—Skin disorder—Travoprost—glaucoma	0.00266	0.00293	CcSEcCtD
Carbimazole—Nervous system disorder—Brinzolamide—glaucoma	0.00265	0.00292	CcSEcCtD
Carbimazole—Angiopathy—Clonidine—glaucoma	0.00265	0.00292	CcSEcCtD
Carbimazole—Rash—Latanoprost—glaucoma	0.00264	0.00291	CcSEcCtD
Carbimazole—Agranulocytosis—Betaxolol—glaucoma	0.00264	0.00291	CcSEcCtD
Carbimazole—Dermatitis—Latanoprost—glaucoma	0.00264	0.00291	CcSEcCtD
Carbimazole—Headache—Latanoprost—glaucoma	0.00262	0.00289	CcSEcCtD
Carbimazole—Skin disorder—Brinzolamide—glaucoma	0.00262	0.00289	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Brimonidine—glaucoma	0.00262	0.00289	CcSEcCtD
Carbimazole—Infection—Pilocarpine—glaucoma	0.00258	0.00284	CcSEcCtD
Carbimazole—Alopecia—Clonidine—glaucoma	0.00258	0.00284	CcSEcCtD
Carbimazole—Nausea—Methazolamide—glaucoma	0.00257	0.00283	CcSEcCtD
Carbimazole—CYP19A1—FSH signaling pathway—BDNF—glaucoma	0.00254	0.0273	CbGpPWpGaD
Carbimazole—Thrombocytopenia—Pilocarpine—glaucoma	0.00254	0.0028	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.0025	0.00276	CcSEcCtD
Carbimazole—CYP19A1—Ovarian Infertility Genes—CCND2—glaucoma	0.00249	0.0267	CbGpPWpGaD
Carbimazole—Musculoskeletal discomfort—Travoprost—glaucoma	0.00249	0.00275	CcSEcCtD
Carbimazole—Feeling abnormal—Acetazolamide—glaucoma	0.00247	0.00272	CcSEcCtD
Carbimazole—Hypersensitivity—Apraclonidine—glaucoma	0.00247	0.00272	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.00246	0.00271	CcSEcCtD
Carbimazole—Urticaria—Acetazolamide—glaucoma	0.00238	0.00262	CcSEcCtD
Carbimazole—Pruritus—Apraclonidine—glaucoma	0.00237	0.00261	CcSEcCtD
Carbimazole—Body temperature increased—Acetazolamide—glaucoma	0.00237	0.00261	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.00236	0.00261	CcSEcCtD
Carbimazole—Ill-defined disorder—Clonidine—glaucoma	0.00236	0.0026	CcSEcCtD
Carbimazole—Angioedema—Clonidine—glaucoma	0.00232	0.00256	CcSEcCtD
Carbimazole—Angiopathy—Betaxolol—glaucoma	0.0023	0.00254	CcSEcCtD
Carbimazole—Pruritus—Bimatoprost—glaucoma	0.0023	0.00253	CcSEcCtD
Carbimazole—Malaise—Clonidine—glaucoma	0.00229	0.00252	CcSEcCtD
Carbimazole—Feeling abnormal—Dorzolamide—glaucoma	0.00226	0.0025	CcSEcCtD
Carbimazole—Feeling abnormal—Travoprost—glaucoma	0.00225	0.00248	CcSEcCtD
Carbimazole—Alopecia—Betaxolol—glaucoma	0.00224	0.00247	CcSEcCtD
Carbimazole—TPO—Differentiation Pathway—VEGFA—glaucoma	0.00223	0.024	CbGpPWpGaD
Carbimazole—Feeling abnormal—Brinzolamide—glaucoma	0.00222	0.00245	CcSEcCtD
Carbimazole—Urticaria—Dorzolamide—glaucoma	0.00218	0.00241	CcSEcCtD
Carbimazole—Body temperature increased—Dorzolamide—glaucoma	0.00217	0.00239	CcSEcCtD
Carbimazole—Arthralgia—Clonidine—glaucoma	0.00216	0.00238	CcSEcCtD
Carbimazole—Agranulocytosis—Timolol—glaucoma	0.00216	0.00238	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.00215	0.00237	CcSEcCtD
Carbimazole—Urticaria—Brinzolamide—glaucoma	0.00214	0.00236	CcSEcCtD
Carbimazole—Feeling abnormal—Pilocarpine—glaucoma	0.00214	0.00236	CcSEcCtD
Carbimazole—Discomfort—Clonidine—glaucoma	0.00214	0.00235	CcSEcCtD
Carbimazole—Hypersensitivity—Brimonidine—glaucoma	0.00212	0.00234	CcSEcCtD
Carbimazole—Dermatitis—Apraclonidine—glaucoma	0.00211	0.00233	CcSEcCtD
Carbimazole—Headache—Apraclonidine—glaucoma	0.0021	0.00231	CcSEcCtD
Carbimazole—Infection—Clonidine—glaucoma	0.00206	0.00227	CcSEcCtD
Carbimazole—Body temperature increased—Pilocarpine—glaucoma	0.00205	0.00226	CcSEcCtD
Carbimazole—Ill-defined disorder—Betaxolol—glaucoma	0.00205	0.00226	CcSEcCtD
Carbimazole—Rash—Bimatoprost—glaucoma	0.00205	0.00226	CcSEcCtD
Carbimazole—Dermatitis—Bimatoprost—glaucoma	0.00205	0.00226	CcSEcCtD
Carbimazole—Pruritus—Brimonidine—glaucoma	0.00203	0.00224	CcSEcCtD
Carbimazole—Headache—Bimatoprost—glaucoma	0.00203	0.00224	CcSEcCtD
Carbimazole—Nervous system disorder—Clonidine—glaucoma	0.00203	0.00224	CcSEcCtD
Carbimazole—Thrombocytopenia—Clonidine—glaucoma	0.00203	0.00224	CcSEcCtD
Carbimazole—Hypersensitivity—Dorzolamide—glaucoma	0.00202	0.00223	CcSEcCtD
Carbimazole—Hypersensitivity—Travoprost—glaucoma	0.00201	0.00222	CcSEcCtD
Carbimazole—Skin disorder—Clonidine—glaucoma	0.00201	0.00222	CcSEcCtD
Carbimazole—Malaise—Betaxolol—glaucoma	0.00199	0.0022	CcSEcCtD
Carbimazole—TPO—Metabolism—CA5A—glaucoma	0.00199	0.0214	CbGpPWpGaD
Carbimazole—TPO—Metabolism—NARFL—glaucoma	0.00199	0.0214	CbGpPWpGaD
Carbimazole—Nausea—Apraclonidine—glaucoma	0.00199	0.00219	CcSEcCtD
Carbimazole—Hypersensitivity—Brinzolamide—glaucoma	0.00199	0.00219	CcSEcCtD
Carbimazole—CYP19A1—Tryptophan metabolism—CYP1B1—glaucoma	0.00198	0.0213	CbGpPWpGaD
Carbimazole—Pruritus—Dorzolamide—glaucoma	0.00194	0.00214	CcSEcCtD
Carbimazole—Pruritus—Travoprost—glaucoma	0.00193	0.00213	CcSEcCtD
Carbimazole—Nausea—Bimatoprost—glaucoma	0.00193	0.00213	CcSEcCtD
Carbimazole—Hypersensitivity—Pilocarpine—glaucoma	0.00191	0.00211	CcSEcCtD
Carbimazole—Pruritus—Brinzolamide—glaucoma	0.00191	0.00211	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Clonidine—glaucoma	0.00189	0.00208	CcSEcCtD
Carbimazole—Angiopathy—Timolol—glaucoma	0.00188	0.00208	CcSEcCtD
Carbimazole—Myalgia—Betaxolol—glaucoma	0.00188	0.00208	CcSEcCtD
Carbimazole—Arthralgia—Betaxolol—glaucoma	0.00188	0.00208	CcSEcCtD
Carbimazole—Headache—Acetazolamide—glaucoma	0.00188	0.00207	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.00187	0.00206	CcSEcCtD
Carbimazole—Discomfort—Betaxolol—glaucoma	0.00186	0.00205	CcSEcCtD
Carbimazole—Pruritus—Pilocarpine—glaucoma	0.00184	0.00202	CcSEcCtD
Carbimazole—Alopecia—Timolol—glaucoma	0.00183	0.00202	CcSEcCtD
Carbimazole—Rash—Brimonidine—glaucoma	0.00181	0.002	CcSEcCtD
Carbimazole—Dermatitis—Brimonidine—glaucoma	0.00181	0.002	CcSEcCtD
Carbimazole—Headache—Brimonidine—glaucoma	0.0018	0.00199	CcSEcCtD
Carbimazole—Infection—Betaxolol—glaucoma	0.00179	0.00198	CcSEcCtD
Carbimazole—Nausea—Acetazolamide—glaucoma	0.00178	0.00196	CcSEcCtD
Carbimazole—Nervous system disorder—Betaxolol—glaucoma	0.00177	0.00195	CcSEcCtD
Carbimazole—Thrombocytopenia—Betaxolol—glaucoma	0.00177	0.00195	CcSEcCtD
Carbimazole—Skin disorder—Betaxolol—glaucoma	0.00175	0.00193	CcSEcCtD
Carbimazole—Rash—Dorzolamide—glaucoma	0.00173	0.00191	CcSEcCtD
Carbimazole—Dermatitis—Dorzolamide—glaucoma	0.00173	0.00191	CcSEcCtD
Carbimazole—Rash—Travoprost—glaucoma	0.00172	0.0019	CcSEcCtD
Carbimazole—Dermatitis—Travoprost—glaucoma	0.00172	0.0019	CcSEcCtD
Carbimazole—Headache—Dorzolamide—glaucoma	0.00172	0.0019	CcSEcCtD
Carbimazole—Headache—Travoprost—glaucoma	0.00171	0.00189	CcSEcCtD
Carbimazole—Nausea—Brimonidine—glaucoma	0.00171	0.00188	CcSEcCtD
Carbimazole—Feeling abnormal—Clonidine—glaucoma	0.00171	0.00188	CcSEcCtD
Carbimazole—Rash—Brinzolamide—glaucoma	0.0017	0.00188	CcSEcCtD
Carbimazole—Dermatitis—Brinzolamide—glaucoma	0.0017	0.00188	CcSEcCtD
Carbimazole—Headache—Brinzolamide—glaucoma	0.00169	0.00186	CcSEcCtD
Carbimazole—Angioedema—Timolol—glaucoma	0.00165	0.00182	CcSEcCtD
Carbimazole—Urticaria—Clonidine—glaucoma	0.00165	0.00182	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Betaxolol—glaucoma	0.00164	0.00181	CcSEcCtD
Carbimazole—Body temperature increased—Clonidine—glaucoma	0.00164	0.00181	CcSEcCtD
Carbimazole—Rash—Pilocarpine—glaucoma	0.00164	0.0018	CcSEcCtD
Carbimazole—Dermatitis—Pilocarpine—glaucoma	0.00163	0.0018	CcSEcCtD
Carbimazole—Nausea—Dorzolamide—glaucoma	0.00163	0.0018	CcSEcCtD
Carbimazole—Headache—Pilocarpine—glaucoma	0.00163	0.00179	CcSEcCtD
Carbimazole—Nausea—Travoprost—glaucoma	0.00162	0.00179	CcSEcCtD
Carbimazole—Nausea—Brinzolamide—glaucoma	0.0016	0.00177	CcSEcCtD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.0016	0.0172	CbGpPWpGaD
Carbimazole—CYP19A1—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.00158	0.017	CbGpPWpGaD
Carbimazole—Nausea—Pilocarpine—glaucoma	0.00154	0.0017	CcSEcCtD
Carbimazole—Myalgia—Timolol—glaucoma	0.00154	0.0017	CcSEcCtD
Carbimazole—Arthralgia—Timolol—glaucoma	0.00154	0.0017	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.00153	0.00168	CcSEcCtD
Carbimazole—Hypersensitivity—Clonidine—glaucoma	0.00153	0.00168	CcSEcCtD
Carbimazole—Discomfort—Timolol—glaucoma	0.00152	0.00167	CcSEcCtD
Carbimazole—Feeling abnormal—Betaxolol—glaucoma	0.00149	0.00164	CcSEcCtD
Carbimazole—Pruritus—Clonidine—glaucoma	0.00147	0.00162	CcSEcCtD
Carbimazole—Infection—Timolol—glaucoma	0.00146	0.00161	CcSEcCtD
Carbimazole—Nervous system disorder—Timolol—glaucoma	0.00145	0.00159	CcSEcCtD
Carbimazole—Urticaria—Betaxolol—glaucoma	0.00143	0.00158	CcSEcCtD
Carbimazole—Skin disorder—Timolol—glaucoma	0.00143	0.00158	CcSEcCtD
Carbimazole—Body temperature increased—Betaxolol—glaucoma	0.00143	0.00157	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Timolol—glaucoma	0.00134	0.00148	CcSEcCtD
Carbimazole—Hypersensitivity—Betaxolol—glaucoma	0.00133	0.00147	CcSEcCtD
Carbimazole—Rash—Clonidine—glaucoma	0.00131	0.00144	CcSEcCtD
Carbimazole—Dermatitis—Clonidine—glaucoma	0.00131	0.00144	CcSEcCtD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.0013	0.0139	CbGpPWpGaD
Carbimazole—Headache—Clonidine—glaucoma	0.0013	0.00143	CcSEcCtD
Carbimazole—Pruritus—Betaxolol—glaucoma	0.00128	0.00141	CcSEcCtD
Carbimazole—Nausea—Clonidine—glaucoma	0.00123	0.00136	CcSEcCtD
Carbimazole—Feeling abnormal—Timolol—glaucoma	0.00121	0.00134	CcSEcCtD
Carbimazole—Urticaria—Timolol—glaucoma	0.00117	0.00129	CcSEcCtD
Carbimazole—Body temperature increased—Timolol—glaucoma	0.00116	0.00128	CcSEcCtD
Carbimazole—Rash—Betaxolol—glaucoma	0.00114	0.00125	CcSEcCtD
Carbimazole—Dermatitis—Betaxolol—glaucoma	0.00114	0.00125	CcSEcCtD
Carbimazole—CYP19A1—Ovarian Infertility Genes—CDKN1B—glaucoma	0.00113	0.0121	CbGpPWpGaD
Carbimazole—Headache—Betaxolol—glaucoma	0.00113	0.00125	CcSEcCtD
Carbimazole—Hypersensitivity—Timolol—glaucoma	0.00109	0.0012	CcSEcCtD
Carbimazole—Nausea—Betaxolol—glaucoma	0.00107	0.00118	CcSEcCtD
Carbimazole—Pruritus—Timolol—glaucoma	0.00104	0.00115	CcSEcCtD
Carbimazole—TPO—Metabolism—CA1—glaucoma	0.000973	0.0104	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CTSA—glaucoma	0.000942	0.0101	CbGpPWpGaD
Carbimazole—Rash—Timolol—glaucoma	0.000929	0.00102	CcSEcCtD
Carbimazole—Dermatitis—Timolol—glaucoma	0.000928	0.00102	CcSEcCtD
Carbimazole—Headache—Timolol—glaucoma	0.000923	0.00102	CcSEcCtD
Carbimazole—TPO—Metabolism—CA2—glaucoma	0.00089	0.00955	CbGpPWpGaD
Carbimazole—Nausea—Timolol—glaucoma	0.000875	0.000965	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—GSTT1—glaucoma	0.000866	0.0093	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—CYP1B1—glaucoma	0.00069	0.00741	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP1B1—glaucoma	0.000681	0.00731	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000645	0.00692	CbGpPWpGaD
Carbimazole—TPO—Metabolism—TXN—glaucoma	0.000627	0.00673	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CA5A—glaucoma	0.000607	0.00652	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NARFL—glaucoma	0.000607	0.00652	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—GSTM1—glaucoma	0.000552	0.00592	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—GSTM1—glaucoma	0.000544	0.00584	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MMP1—glaucoma	0.000521	0.00559	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTT1—glaucoma	0.000486	0.00522	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BAD—glaucoma	0.00047	0.00504	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ABCA1—glaucoma	0.000387	0.00416	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP1B1—glaucoma	0.000387	0.00416	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTM1—glaucoma	0.00031	0.00332	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CA1—glaucoma	0.000297	0.00318	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CTSA—glaucoma	0.000287	0.00308	CbGpPWpGaD
Carbimazole—TPO—Metabolism—MTHFR—glaucoma	0.000274	0.00294	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—glaucoma	0.000272	0.00292	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CA2—glaucoma	0.000271	0.00291	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000265	0.00285	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000265	0.00285	CbGpPWpGaD
Carbimazole—TPO—Metabolism—APOE—glaucoma	0.000255	0.00273	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CAV1—glaucoma	0.000252	0.00271	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—TP53—glaucoma	0.000206	0.00221	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—TXN—glaucoma	0.000191	0.00205	CbGpPWpGaD
Carbimazole—TPO—Metabolism—NOS3—glaucoma	0.000191	0.00205	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PTGS2—glaucoma	0.000175	0.00187	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000174	0.00187	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000173	0.00185	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTT1—glaucoma	0.000148	0.00159	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	0.000119	0.00128	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ABCA1—glaucoma	0.000118	0.00127	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP1B1—glaucoma	0.000118	0.00127	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTM1—glaucoma	9.44e-05	0.00101	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—MTHFR—glaucoma	8.34e-05	0.000895	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—APOE—glaucoma	7.77e-05	0.000833	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CAV1—glaucoma	7.69e-05	0.000826	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NOS3—glaucoma	5.82e-05	0.000624	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PTGS2—glaucoma	5.32e-05	0.000571	CbGpPWpGaD
